Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0037315 (sleep apnea)
 8,000 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A comprehensive cephalometric analysis of uvulo-glossopharyngeal morphology in 100 patients with obstructive sleep apnoea (OSA) and 36 controls was performed. The aberrations in OSA patients included: 1. Increased length, thickness, and sagittal area of soft palate (PM-U; SPT; SPA: P < 0.001) with a more upright position (NL/PM-U: P < 0.05) and 15 per cent more pharyngeal area occupation [SPA/(OPA-OA): P < 0.001]. 2. The contact length between the soft palate and the tongue was increased approximately two-fold (CL: P < 0.001). 3. The sagittal area of the tongue was 10 per cent larger (TA: P < 0.001) despite similar length and height and 3 per cent more oral area occupation (TA/OA: P < 0.05). 4. More upright tongue position (VT/FH: P < 0.05) and caudally extended tongue mass (V perpendicular FH: P < 0.05). 5. Decreased sagittal dimensions of nasopharynx (pm-UPW: P < 0.001), velopharynx (U-MPW: P < 0.001) and minimum distance between the base of the tongue and the posterior pharyngeal wall (PASmin: P < 0.001). 6. The residual oropharyngeal area (area not occupied by soft tissues) was 9 per cent less due to larger tongue and soft palate [(TA+SPA)/OPA: P < 0.001]. Cephalometric analysis is highly recommended in OSA patients as one of the most important tools in diagnosis and treatment planning.
 ...
PMID:Obstructive sleep apnoea: a cephalometric study. Part II. Uvulo-glossopharyngeal morphology. 773 46

The effects of administration of N(6)-p-sulfophenyladenosine (p-SPA), a peripheral adenosine A(1) receptor agonist, and 8-(p-sulfophenyl)theophylline (p-SPT), a peripheral adenosine A(1) receptor blocker, on spontaneous apneas were studied in 10 adult Sprague-Dawley rats by monitoring respiration, sleep, and blood pressure for 6 h. Intraperitoneal injection of p-SPA (1 mg/kg) to rats suppressed spontaneous central apneas during non-rapid eye movement sleep by 50% in comparison to control recordings (p = 0.03). This effect was blocked by pretreatment with an equimolar dose of p-SPT (0.67 mg/kg) indicating that p-SPA suppression of apneas was receptor mediated in the peripheral nervous system. Administration of p-SPA did not affect apnea expression in rapid eye movement sleep and had no effect on sleep or blood pressure at the dose tested. Administration of p-SPT (0.67, 6.7, and 30 mg/kg) to rats had no effect on apneas, sleep, or blood pressure. The lack of p-SPT effect on sleep apneas argues against a physiologic role for endogenous adenosine in the peripheral nervous system as a modulator of sleep apnea expression under baseline conditions.
 ...
PMID:Role of peripheral adenosine A(1) receptors in the regulation of sleep apneas in rats. 1050 26